Acciones Isodiol International Inc Canadian Securities Exchange
Acciones
CA46500L1013
Farmacéuticos
Ventas 2018 | 19,14 M 26,18 M 17,79 M | Ventas 2019 | 22,25 M 30,43 M 20,68 M | Capitalización | 49,96 M 68,33 M 46,44 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -36 M -49,24 M -33,47 M | Resultado Neto 2019 | -126 M -172 M -117 M | VE / Ventas 2018 | 12,6 x |
Posición de caja neta 2018 | 15,55 M 21,27 M 14,45 M | Deuda neta 2019 | 5,22 M 7,14 M 4,85 M | VE / Ventas 2019 | 2,48 x |
P/E ratio 2018 |
-4,94
x | P/E ratio 2019 |
-0,37
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+27,29 % | 5560,06 M | |
-33,07 % | 3547,6 M | |
-3,24 % | 3009,1 M | |
-24,56 % | 2638,09 M | |
-10,17 % | 2302,09 M | |
+46,81 % | 1948,21 M | |
+48,03 % | 1522,13 M | |
-11,69 % | 1448,06 M | |
+43,81 % | 1382,19 M |